CRLconf 0.85
balstilimab — CRL
$AGEN · AGENUS INC · second-line cervical cancer
Event date
Date TBD
Sponsor runway
3 mo
$35.0M liquid
Evidence
Comparable historical crls· last 5 years · same event type
No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.
Recent insider activity· ±90 days
8 insiders · 0 buys · 0 sells
Grant
2026-05-15ARMEN GARO H
See Remarks
4,540 @ $3.58$16K
Grant
2026-05-01ARMEN GARO H
See Remarks
4,233 @ $3.84$16K
Grant
2026-04-24O'Day Steven J
Chief Medical Officer
95,333 @ ——
Grant
2026-04-24Buell Jennifer
See Remarks
5,000 @ ——
Grant
2026-04-24Charette Austin
Principal Accounting Officer
5,000 @ ——
Grant
2026-04-24Charette Austin
Principal Accounting Officer
17,619 @ ——
Grant
2026-04-24O'Day Steven J
Chief Medical Officer
70,000 @ ——
Grant
2026-04-24HARRISON THOMAS L
Director
122,500 @ ——
Grant
2026-04-24ARMEN GARO H
See Remarks
1,000,000 @ ——
Grant
2026-04-24ARMEN GARO H
See Remarks
27,750 @ ——
Grant
2026-04-24ARMEN GARO H
See Remarks
137,550 @ ——
Grant
2026-04-24Corvese Brian
Director
210,000 @ ——
Grant
2026-04-24Wright Timothy
Director
105,000 @ ——
Grant
2026-04-24Hirsch Susan B
Director
105,000 @ ——
Grant
2026-04-24Buell Jennifer
See Remarks
300,000 @ ——
Grant
2026-04-17ARMEN GARO H
See Remarks
3,403 @ $4.79$16K
Grant
2026-04-03ARMEN GARO H
See Remarks
4,629 @ $3.33$15K
Grant
2026-04-01HARRISON THOMAS L
Director
9,228 @ $3.32$31K
Grant
2026-04-01Wright Timothy
Director
2,448.256 @ ——
Grant
2026-03-20ARMEN GARO H
See Remarks
3,983 @ $3.71$15K